10 Most Oversold S&P 500 Stocks So Far in 2026

Page 4 of 4

6. Zoetis Inc. (NYSE:ZTS)

Share Price Decline Versus 52-Week High: 54.55%

Relative Strength Index: 26.21

Number of Hedge Fund Holders: 57

Zoetis Inc. (NYSE:ZTS) is among the 10 Most Oversold S&P 500 Stocks So Far in 2026. On May 27, Argus Research analyst Jasper Hellweg downgraded the stock to Hold from Buy.

The firm noted growing competition and a shift in demand in the animal health market as the reason behind the adjustment. Argus also mentioned the risk of cannibalization with the company’s leading pipeline products likely to adversely impact the sales of its current portfolio.

The update follows Stifel’s adjustment on May 22 when it trimmed the price target on Zoetis Inc. (NYSE:ZTS) to $95 from $105 and reiterated a Hold rating. The firm believes that while the company’s revised guidance for 2026 hints at an improvement, competitive pressures “appear poised to intensify” in the short-term.

As of the close of business on May 29, Wall Street has a Moderate Buy rating on the stock with an average share price upside potential of 53%.

The company missed Wall Street’s expectations for both revenue and profit in Q1 and cut its full-year guidance, as a cautious consumer environment continues to impact demand for veterinary visits and premium pet treatments.

Zoetis Inc. (NYSE:ZTS) is a global animal health company focused on developing and commercializing vaccines and medications.

While we acknowledge the potential of ZTS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ZTS and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Most Oversold S&P 500 Stocks So Far in 2026.

Disclosure: None. Follow Insider Monkey on Google News.

Page 4 of 4
1281292 - 11759070 - 1